We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| IDOX PLC | AQSE:IDOX.GB | Aquis Stock Exchange | Ordinary Share | GB0002998192 | Ordinary Shares 1p |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 62.50 | 59.00 | 65.20 | 62.50 | 62.00 | 62.50 | 0.00 | 15:29:18 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Sep 2019 to Sep 2024
TIDMIDOX
RNS Number : 1571Z
IDOX PLC
13 December 2017
Idox plc
("Idox", the "Company" or the "Group")
Year End Update and Board Change
Idox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, today provides a further update on results for its financial year ended 31 October 2017 (further to the announcement dated 14 November 2017).
Following internal review in preparation for the full year audit, the Company has identified a small number of revenue items that it does not consider should be recognised in the FY2017 results, which are expected to reduce EBITDA for FY2017 to approximately GBP20m (compared to about GBP23m stated in the announcement of 14 November, and GBP21.5m in 2016). These matters were identified internally and have been brought to the attention of Idox's auditors by the Company.
Clarification of these issues has been complicated by the sudden absence of Andrew Riley, Idox's CEO, due to illness. Richard Kellett-Clarke, currently a non-Executive Director and former CEO of Idox, has agreed to stand in as Interim CEO pending Andrew's return from sick leave.
Final Results
As a result of the matters above, the Board expects that the Company's final results for the 2017 financial year will be announced in February 2018.
This announcement is released by Idox plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the update and board change described herein, and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Jane Mackie, Director.
Enquiries:
Idox plc +44 (0) 870 333 7101
Laurence Vaughan, Non-Executive Chairman
Richard Kellett-Clarke, Interim Chief Executive
Jane Mackie, Chief Financial Officer
N+1 Singer (NOMAD and Broker) +44 (0) 20 7496 3000
Shaun Dobson
Liz Yong
MHP (Financial PR) +44 (0) 20 3128 8100
Reg Hoare
Andrew Leach
Charlie Barker
This information is provided by RNS
The company news service from the London Stock Exchange
END
UPDTTBTTMBABTJR
(END) Dow Jones Newswires
December 13, 2017 02:00 ET (07:00 GMT)
1 Year IDOX Chart |
1 Month IDOX Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
